T2 patients may be at increased risk of developing tangles in the brain that indicate dementia.
Read More »The Value of the Nitric Oxide Pathway and its Importance in African-American Patients with Heart Failure
Studies in heart failure and hypertension have shown that people who identify themselves as black may have a less active renin-angiotensin system and a lower bioavailability of nitric oxide. The A-HeFT study was conducted to determine if a fixed dose of isosorbide dinitrate (ISDN) and hydralazine would provide additional benefit in black patients with heart failure.
Read More »Discontinuation of TZD Reduces Fracture Rates
Thiazolidinediones (TZDs), rosiglitazone and pioglitazone, have been shown to increase fracture risk in women after a year of TZD use; however, there has been little data available on the effects of the discontinuation of TZD. This longitudinal observational cohort study used data from an ancillary study of skeletal health within …
Read More »Finerenone Improves Albuminuria in Diabetic Nephropathy Patients
Mineralocorticoid receptor antagonists (MRAs) are often used with a renin-angiotensin system (RAS) blocker to further reduce proteinuria in patients with CKD. However, eplerenone and spironolactone increase the risk of hyperkalemia in these patients. Finerenone (BAY94-8862) is a new nonsteroidal MRA that has better receptor selectivity than spironolactone, associating with lower …
Read More »FDA Warning: Invokana Can Increase Risk of Bone Fracture
Bone mineral density at hip and lower spine may also decrease.
Read More »Delayed Stomach-Emptying: Gastroparesis – Part 1
Diabetes Solution Richard K. Bernstein, MD, FACE, FACN, FACCWS Part 1 Chapter 22 Gastroparesis Anumber of times throughout this book, you’ve come across the terms “delayed stomach-emptying” and “gastroparesis.” As I explained in Chapter 2, elevated blood sugars for prolonged periods can impair the ability of nerves to function properly. …
Read More »How Does Gastroparesis Affect Blood Sugar Control? – Part 2
Diabetes Solution Richard K. Bernstein, MD, FACE, FACN, FACCWS Part 2 Chapter 22 Gastroparesis How Does Gastroparesis Affect Blood Sugar Control? – Part 2Consider the individual who has very little phase I insulin release and must take fast-acting insulin or one of the older-type (sulfonylurea) or newer pancreas-provoking OHAs before …
Read More »Diagnosing Gastroparesis – Part 3
Diabetes Solution Richard K. Bernstein, MD, FACE, FACN, FACCWS Part 3 Chapter 22 Gastroparesis Efforts at diagnosis are usually unnecessary if there is no reason to suspect the presence of gastroparesis. So first we must have an index of suspicion. If, at the initial history-taking interview with your physician, you …
Read More »Diagnosing Gastroparesis – Part 4
Diabetes Solution Richard K. Bernstein, MD, FACE, FACN, FACCWS Part 4 Chapter 22 Gastroparesis It is worth noting that gastroparesis can be cured by extended periods of normal blood sugars. I’ve seen several relatively mild cases where special treatment was terminated after about 1 year, and blood sugar profiles remained …
Read More »Diagnosing Gastroparesis – Part 5
Diabetes Solution Richard K. Bernstein, MD, FACE, FACN, FACCWS Part 5 Chapter 22 Gastroparesis Super Papaya Enzyme Plus has been praised by many of my patients for its rapid relief of some of the physical symptoms of gastroparesis— bloating and belching, for example. Some claim that it also helps to …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.